Huaixin Xing

Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab

Juntao Pang, Huaixin Xing, Yingui Sun et al. · Biomedicine & Pharmacotherapy · 2020 · 102 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

<scp>RUNX</scp>3 regulates vimentin expression <i>via</i> miR‐30a during epithelial–mesenchymal transition in gastric cancer cells

Zhifang Liu, Long Chen, Xinchao Zhang et al. · Journal of Cellular and Molecular Medicine · 2014 · 96 citations · Full text

Medicine, Cancer Biology, Oncology +16

Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: In vitro and in vivo evaluation

Pengju Ma, Ting Li, Huaixin Xing et al. · Biomedicine & Pharmacotherapy · 2017 · 58 citations

Medicine, Anesthesiology, Pharmacology +16

F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a

Xinchao Zhang, Ye Kong, Xia Xu et al. · Oncotarget · 2014 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +16

EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC

Jupeng Yuan, Huaixin Xing, Yankang Li et al. · Cancer Letters · 2020 · 31 citations

Life Sciences, Cell Biology, Oncology +14